CBS 2019
CBSMD教育中心
中 文

ASCVD Prevention

Abstract

Recommended Article

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy 2010 ACCF/AHA guideline for assessment of cardiovascular risk in asymptomatic adults: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines The Prevalence of Myocardial Bridging Associated with Coronary Endothelial Dysfunction in Patients with Chest Pain and Non-Obstructive Coronary Artery Disease Ten-year association of coronary artery calcium with atherosclerotic cardiovascular disease (ASCVD) events: the multi-ethnic study of atherosclerosis (MESA) Myocardial bridging: contemporary understanding of pathophysiology with implications for diagnostic and therapeutic strategies Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes When, where, and how to target vascular inflammation in the post-CANTOS era?

Clinical Case Study2017 Sep;42(9):e400-e402.

JOURNAL:Clin Nucl Med. Article Link

Noninvasive Nuclear SPECT Myocardial Blood Flow Quantitation to Guide Management for Coronary Artery Disease

Chen LC, Jong BH, Lin SC et al. Keywords: myocardial blood flow quantitation; dynamic SPECT; multivessel coronary artery disease; myocardial perfusion

ABSTRACT

Recently, myocardial bloodflow quantitation with dynamic SPECT has been validated to enhance the detection of multivessel coronary artery disease (CAD) and conclude equivocal SPECT myocardial perfusion study. This advance opened an important clinical application to utilize the tool in guiding CAD management for area where myocardial perfusion tracers for PET are unavailable or unaffordable. We present a clinical patient with ongoing recursive angina who underwent multiple nuclear stress tests for a sequence of CAD evaluation in 26 months and demonstrated that SPECT myocardial bloodflow quantitation properly guided CAD management to warrant patient outcome.